AVTXVSGOSS• 7 Days (Normalized)
AVTX vs GOSS (Avalo Therapeutics Inc. vs Gossamer Bio Inc.)
Showing Closing Date Range from Sep, 07 to Sep, 14, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVTX Performance $16.18
-17.91%
Avalo Therapeutics Inc.
Normalized Baseline0.00%
GOSS Performance $10.7
-25.69%
Gossamer Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin AVTX LEADS
+7.78%
AVTX outperforming by 7.78%
AVTXGOSS
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVTX GOSS
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | AVTX Price | AVTX Gain (%) | GOSS Price | GOSS Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 14, 2026 | $16.18 | -17.91% | $10.70 | -25.69% | +7.78% |
| Sep 11, 2026 | $16.12 | -18.21% | $10.73 | -25.49% | +7.28% |
| Sep 10, 2026 | $17.18 | -12.84% | $11.36 | -21.11% | +8.27% |
| Sep 09, 2026 | $18.21 | -7.61% | $12.80 | -11.11% | +3.50% |
| Sep 08, 2026 | $19.71 | +0.00% | $14.40 | +0.00% | +0.00% |